Friess Associates LLC Assertio Holdings, Inc. Transaction History
Friess Associates LLC
- $59.9 Million
- Q2 2022
A detailed history of Friess Associates LLC transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Friess Associates LLC holds 766,650 shares of ASRT stock, worth $636,319. This represents 3.78% of its overall portfolio holdings.
Number of Shares
766,650
Previous 1,196,452
35.92%
Holding current value
$636,319
Previous $3.43 Million
34.13%
% of portfolio
3.78%
Previous 1.83%
Shares
3 transactions
Others Institutions Holding ASRT
# of Institutions
85Shares Held
26.7MCall Options Held
449KPut Options Held
60K-
Nantahala Capital Management, LLC New Canaan, CT8.81MShares$7.31 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.64 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.82MShares$2.34 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.15 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.02MShares$847,7470.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $40M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...